The research significance of concomitant use of CAR-CD138-NK and CAR-CD19-NK to target multiple myelomas
Multiple myeloma (MM) is a type of cancer characterized by abnormal proliferation of clonal cells; it is the very dangerous and highly prevalent disease. Although significant progress has been made in clinical research, especially with novel drugs such as bortezomib, lenalidomide, and carfilzomib, m...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-07-01
|
| Series: | European Journal of Inflammation |
| Online Access: | https://doi.org/10.1177/2058739218788968 |